.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
McKesson
AstraZeneca
Teva
US Army
Johnson and Johnson
Medtronic
Cantor Fitzgerald
Baxter
Covington

Generated: September 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020125

« Back to Dashboard
NDA 020125 describes ACCURETIC, which is a drug marketed by Pfizer Pharms and is included in one NDA. It is available from two suppliers. Additional details are available on the ACCURETIC profile page.

The generic ingredient in ACCURETIC is hydrochlorothiazide; quinapril hydrochloride. There are thirty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.

Summary for NDA: 020125

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 020125

Ingredient-typeThiazides
Mechanism of ActionAngiotensin-converting Enzyme Inhibitors
Physiological EffectIncreased Diuresis

Suppliers and Packaging for NDA: 020125

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACCURETIC
hydrochlorothiazide; quinapril hydrochloride
TABLET;ORAL 020125 NDA Parke-Davis Div of Pfizer Inc 0071-0220 0071-0220-23 90 TABLET, FILM COATED in 1 BOTTLE (0071-0220-23)
ACCURETIC
hydrochlorothiazide; quinapril hydrochloride
TABLET;ORAL 020125 NDA Parke-Davis Div of Pfizer Inc 0071-0222 0071-0222-23 90 TABLET, FILM COATED in 1 BOTTLE (0071-0222-23)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength12.5MG;EQ 10MG BASE
Approval Date:Dec 28, 1999TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength12.5MG;EQ 20MG BASE
Approval Date:Dec 28, 1999TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;EQ 20MG BASE
Approval Date:Dec 28, 1999TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 020125



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
McKesson
Medtronic
Julphar
Chinese Patent Office
Teva
Harvard Business School
Farmers Insurance
UBS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot